Holen Sie sich die Stockscreener-App
38.84
7.26%
2.63
Schlusskurs vom Vortag:
$36.21
Offen:
$36.85
24-Stunden-Volumen:
55,564
Relative Volume:
1.31
Marktkapitalisierung:
$239.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.12M
KGV:
-16.89
EPS:
-2.3
Netto-Cashflow:
$-6.82M
1W Leistung:
+7.71%
1M Leistung:
-6.97%
6M Leistung:
+22.52%
1J Leistung:
+1,492%
1-Tages-Spanne:
$35.01
$38.86
1-Wochen-Bereich:
$32.77
$38.86
52-Wochen-Spanne:
$2.2901
$54.30
Monopar Therapeutics Inc Stock (MNPR) Company Profile
Firmenname
Monopar Therapeutics Inc
Sektor
Branche
Telefon
(847) 388-0349
Adresse
1000 SKOKIE BLVD SUITE 350, WILMETTE
Vergleichen Sie MNPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNPR
Monopar Therapeutics Inc
|
38.84 | 209.35M | 0 | -7.12M | -6.82M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-26 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-19 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-01-10 | Eingeleitet | Piper Sandler | Overweight |
| 2024-10-11 | Eingeleitet | Rodman & Renshaw | Buy |
| 2021-01-28 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Monopar Therapeutics Inc Aktie (MNPR) Neueste Nachrichten
AlphaQuest LLC Makes New $44,000 Investment in Monopar Therapeutics Inc. $MNPR - Defense World
Is Monopar Therapeutics Inc. stock suitable for long term investing2025 EndofYear Setup & Short-Term Trading Alerts - khodrobank.com
Applying big data sentiment scoring on Monopar Therapeutics Inc.Portfolio Profit Report & Weekly Stock Performance Updates - Newser
Is Monopar Therapeutics Inc. currently under institutional pressureWeekly Trade Recap & High Conviction Buy Zone Picks - khodrobank.com
Monopar Therapeutics: A Speculative Buy On 2 Fronts With Catalysts Imminent (NASDAQ:MNPR) - Seeking Alpha
Is Monopar Therapeutics Inc.’s growth already priced inJuly 2025 Big Picture & AI Powered Buy and Sell Recommendations - khodrobank.com
Best data tools to analyze Monopar Therapeutics Inc. stock2025 Macro Impact & Free Accurate Trade Setup Notifications - Newser
Will Monopar Therapeutics Inc. bounce back from current supportWeekly Market Report & Low Volatility Stock Recommendations - Newser
Should you hold or exit Monopar Therapeutics Inc. nowLayoff News & AI Based Buy and Sell Signals - Newser
Visual analytics tools that track Monopar Therapeutics Inc. performanceWeekly Trade Review & Smart Investment Allocation Tips - Newser
Will Monopar Therapeutics Inc. outperform the marketGlobal Markets & Daily Technical Forecast Reports - Newser
How to escape a deep drawdown in Monopar Therapeutics Inc.Jobs Report & Accurate Technical Buy Alerts - Newser
Is Monopar Therapeutics Inc. stock showing strong momentumEarnings Miss & Reliable Intraday Trade Plans - khodrobank.com
Evaluating Monopar Therapeutics Inc. with trendline analysisWeekly Market Report & Weekly High Momentum Picks - Newser
Monopar a new outperform at Oppenheimer on Wilson disease candidate - Seeking Alpha
How moving averages guide Monopar Therapeutics Inc. tradingWeekly Gains Summary & High Conviction Trade Alerts - Newser
Will Monopar Therapeutics Inc. stock recover after earningsJuly 2025 Spike Watch & Weekly Watchlist of Top Performers - khodrobank.com
Monopar Announces Abstract Accepted with Distinction for Oral and Poster Presentations at the Upcoming American Neurological Association 2025 Annual Meeting - The Manila Times
Monopar's Wilson Disease Drug Study Selected for ANA 2025 Meeting | MNPR Stock News - Stock Titan
Raymond James Initiates Monopar Therapeutics at Strong Buy With $80 Price Target - MarketScreener
Detecting price anomalies in Monopar Therapeutics Inc. with AIQuarterly Profit Review & Reliable Price Action Trade Plans - Newser
Will Monopar Therapeutics Inc. see short term momentum2025 Technical Patterns & Long-Term Safe Investment Plans - Newser
Risk vs reward if holding onto Monopar Therapeutics Inc.Portfolio Growth Summary & Intraday High Probability Setup Alerts - Newser
Sentiment analysis tools applied to Monopar Therapeutics Inc2025 Risk Factors & Technical Buy Zone Confirmations - Newser
Sentiment analysis tools applied to Monopar Therapeutics Inc.July 2025 Trends & Real-Time Chart Breakout Alerts - Newser
What analysts say about Monopar Therapeutics Inc. stockMarket Growth Report & Entry and Exit Point Strategies - khodrobank.com
Real time pattern detection on Monopar Therapeutics Inc. stockPortfolio Growth Summary & High Accuracy Trade Alerts - Newser
Statistical indicators supporting Monopar Therapeutics Inc.’s strengthStop Loss & Daily Stock Trend Reports - Newser
Published on: 2025-09-02 23:38:23 - Newser
Using data models to predict Monopar Therapeutics Inc. stock movementPortfolio Gains Summary & Smart Allocation Stock Reports - Newser
Visualizing Monopar Therapeutics Inc. stock with heatmaps2025 Bull vs Bear & Free Long-Term Investment Growth Plans - Newser
Published on: 2025-09-02 12:19:21 - Newser
Technical Charts Suggest Momentum Shift in Monopar Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Can Monopar Therapeutics Inc. outperform in the next rallyForecast Cut & Weekly Stock Breakout Alerts - khodrobank.com
Why Monopar Therapeutics Inc. is moving todayJuly 2025 Market Mood & Weekly Momentum Picks - Newser
Will Monopar Therapeutics Inc. price bounce be sustainableWeekly Trade Recap & High Return Trade Opportunity Guides - Newser
Is Monopar Therapeutics Inc. stock reversal real or fakeGap Up & Free Technical Confirmation Trade Alerts - Newser
Can machine learning forecast Monopar Therapeutics Inc. recoveryPortfolio Risk Report & Weekly High Potential Stock Alerts - Newser
Price Action Confirms Reversal in Monopar Therapeutics Inc. Trend getLinesFromResByArray error: size == 0 - kangso.co.kr
What’s the RSI of Monopar Therapeutics Inc. stockJuly 2025 Big Picture & AI Powered Market Trend Analysis - khodrobank.com
Monopar Therapeutics Inc. Reversal Rally May Surprise Bears getLinesFromResByArray error: size == 0 - 강소기업뉴스
Custom strategy builders for tracking Monopar Therapeutics Inc.CEO Change & AI Based Buy and Sell Signals - Newser
Monopar Therapeutics Inc. Stocks Attracting Dip Buyers getLinesFromResByArray error: size == 0 - thegnnews.com
Published on: 2025-08-31 12:56:46 - Newser
Using fundamentals and technicals on Monopar Therapeutics Inc.July 2025 Analyst Calls & Intraday High Probability Setup Alerts - Newser
Will Monopar Therapeutics Inc. stock go up soon2025 Sector Review & Technical Analysis for Trade Confirmation - Newser
What the charts say about Monopar Therapeutics Inc. todayWeekly Trade Report & AI Powered Buy/Sell Recommendations - Newser
Has Monopar Therapeutics Inc. found a price floorJuly 2025 Short Interest & Verified High Yield Trade Plans - Newser
Finanzdaten der Monopar Therapeutics Inc-Aktie (MNPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Monopar Therapeutics Inc-Aktie (MNPR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| STARR CHRISTOPHER M | Director |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
5,173 |
| Robinson Chandler | Chief Executive Officer |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
73,472 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):